home Latest News Top Ranked Value Stocks to Buy for April 16th – Zacks.com

Top Ranked Value Stocks to Buy for April 16th – Zacks.com

This post was originally published on this site

Here are four stocks with buy rank and strong value characteristics for investors to consider today, April 16th:

The Marcus Corporation (MCS Free Report) : This operator of movie theatres, and hotels and resorts has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings increasing 10.4% over the last 60 days.

Marcus Corporation (The) Price and Consensus

Marcus has a price-to-earnings ratio (P/E) of 17.13 compared with 40.00 for the industry. The company possesses a Value Score of A.

Marcus Corporation (The) PE Ratio (TTM)

SP Plus Corporation (SP Free Report) : This business services provider has a Zacks Rank #2 (Buy) and seen the Zacks Consensus Estimate for its current year earnings increasing 18.8% over the last 60 days.

SP Plus Corporation Price and Consensus

SP has a price-to-earnings ratio (P/E) of 15.86, compared with 24.50 for the industry. The company possesses a Value Score of A.

SP Plus Corporation PE Ratio (TTM)

Veritiv Corporation (VRTV Free Report) : This distributor of packaging solutions has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 23.7% over the last 60 days.

Veritiv Corporation Price and Consensus

Veritiv has a price-to-earnings ratio (P/E) of 9.40, compared with 13.60 for the industry. The company possesses a Value Score of A.

Veritiv Corporation PE Ratio (TTM)

Nordstrom, Inc. (JWN Free Report) : This fashion retailer has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings advancing 9.3% over the last 60 days.

Nordstrom, Inc. Price and Consensus

Nordstrom has a price-to-earnings ratio (P/E) of 13.85, compared with 19.00 for the industry. The company possesses a Value Score of A.

Nordstrom, Inc. PE Ratio (TTM)

See the full list of top ranked stocks here

Learn more about the Value score and how it is calculated here.

Investor Alert: Breakthroughs Pending

A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.

Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.

Click here to see them >>